UFlex Q1 FY27: Revenue +38%, margin at 21-quarter high

UFlex Limited (NSE: UFLEX; BSE: 500148) reported a sharp improvement in profitability in Q1 FY27, supported by higher realizations, operational efficiency gains and a stronger contribution from overseas operations. The company presented its Q1 FY27 earnings on August 17, 2026, and said the quarter marked its highest EBITDA performance in 21 quarters.

On a consolidated basis, revenue from operations rose 38% year-on-year to Rs 5,397.2 crore, while EBITDA jumped 92% to Rs 919.8 crore. EBITDA margin expanded 480 basis points year-on-year to 17%. Net profit after tax increased to about Rs 423 crore versus roughly Rs 62 crore in the year-ago quarter.

Key numbers from the quarter

The company reported consolidated revenue growth of 38% year-on-year, with a strong step-up in operating profit. Management attributed margin expansion to operational efficiency, stronger realizations and currency tailwinds.

UFlex also disclosed that its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 were approved by the Board and reviewed by the Audit Committee. The company said the transcript of the call would be made available shortly on its website.

EBITDA at a 21-quarter high

A standout in the quarter was the step-up in profitability. EBITDA rose 92% year-on-year to Rs 919.8 crore, and margin expanded to 17%, the highest level in 21 quarters. The company also reported that normalized EBITDA increased to Rs 837.3 crore, up 78.2% year-on-year.

The margin expansion is notable because it came alongside a stated strategic shift in the product mix toward higher-margin categories, even as some packaging volumes were under pressure.

Profit growth and improved earnings profile

Net profit after tax rose to Rs 422.2 crore in Q1 FY27, compared with Rs 61.9 crore in Q1 FY26. Profit before tax and exceptional items was reported at Rs 490.5 crore versus Rs 93.3 crore a year earlier.

Earnings per share (basic and diluted) for Q1 FY27 was Rs 58.62, compared with Rs 8.03 in Q1 FY26 and Rs 27.15 in Q4 FY26, based on the company’s reported figures.

Overseas operations did the heavy lifting

UFlex’s earnings summary noted that overseas operations contributed 80% of revenue and 91% of incremental EBITDA in Q1 FY27. Egypt, Mexico, and Nigeria were cited as key drivers.

This overseas skew matters for investors because it can change sensitivity to regional demand cycles, currency moves and import competition in specific markets. Management also linked the quarter’s outcome to better pricing and new capacity coming online.

Packaging volumes: strategic mix shift and import pressure

While profitability improved, the company flagged volume pressures in parts of the business. Overall packaging volumes declined 8.4% year-on-year due to a strategic shift to high-margin products and softness in aseptic packaging.

Management said aseptic packaging volumes were impacted by aggressive pricing from duty-free imports, particularly from Indonesia, which pressured the segment. In Europe, sales volumes remained flat year-on-year amid continued pressure from low-priced imports, and demand was expected to moderate in the next quarter.

India packaging film volumes: QoQ improvement

Within India packaging films, the company reported a quarter-on-quarter rise in sales volume. India packaging film sales volume increased 9.1% quarter-on-quarter to 29,323 metric tons.

This data point provides a counterbalance to the broader packaging volume commentary, indicating that volume trends were not uniform across all geographies and product lines.

Guidance: 35% growth target for FY27

Management guided for 35% top-line and EBITDA growth in FY27 and said its outlook remained positive through FY29, driven by new capacities and a focus on value-added products.

The company also projected a full-year EBITDA margin above 14%, with Q1’s reported EBITDA margin at 17% and normalized margin cited at 15.5% for the quarter.

Capex and balance sheet snapshot

UFlex reported capex of Rs 478.2 crore in Q1 FY27 and net debt of Rs 8,587.5 crore. These figures are useful for tracking how expansion plans and capacity additions translate into leverage and cash flow over subsequent quarters.

Stock reaction after results

Market reaction was sharply positive in trading following the numbers and guidance. One report noted the stock rose up to 19.99% to Rs 586.05 from a previous close of Rs 488.40, approaching a 52-week high of Rs 595.40. Another snapshot cited the stock up 17.18% to Rs 572.30 after the results.

Summary table: Q1 FY27 scorecard

Why the quarter matters

The quarter combined strong earnings growth with a clear margin inflection, supported by realizations, operating efficiency, and the overseas manufacturing footprint. At the same time, UFlex’s commentary highlights the trade-off between higher-margin mix and reported volume growth, particularly where duty-free imports are impacting pricing.

For investors, the main monitorables from here are whether management can sustain the guided 35% growth in revenue and EBITDA in FY27, how import competition affects aseptic and European demand, and how new capacities and capex translate into consistent margins above the company’s stated full-year threshold.

What to watch next

UFlex’s management expects momentum to continue through FY29 on the back of capacity additions and a value-added product focus. The next quarter will likely provide more evidence on whether the Europe demand moderation materialises and how the company navigates duty-free import pricing in aseptic packaging. The company has also indicated that the earnings call transcript will be made available on its website for detailed discussion points.